LODINE

This brand name is authorized in France, Turkey, United Kingdom

Active ingredients

The drug LODINE contains one active pharmaceutical ingredient (API):

1 Etodolac
UNII 2M36281008 - ETODOLAC

Etodolac is a non-steroidal anti-inflammatory drug (NSAID). Studies in-vitro and in human cell models have confirmed that etodolac is selective for the inhibition of COX-2. Experiments have shown etodolac to have marked anti-inflammatory activity, being more potent than several clinically established NSAIDs.

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LODINE SR Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AB08 Etodolac M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 68032346, 68645185
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 26093
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699033090014, 8699033090021, 8699033090427

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.